2010 study posted for filing Contact: Karl Oestreich firstname.lastname@example.org 507-284-5005 Mayo Clinic Mayo Clinic has conducted the first clinical studies of tea extract in cancer patients CHICAGO — ASCO Abstract Number: 6522 (http://abstract.asco.org/AbstView_74_47574.html). An extract of green tea appears to have clinical activity with low toxicity in chronic […]
Green tea extract shows promise in leukemia trials: Chronic lymphocytic leukemia 50 percent or greater decline in their lymph node size.
2009 study posted for filing ROCHESTER, Minn. — Mayo Clinic researchers are reporting positive results in early leukemia clinical trials using the chemical epigallocatechin gallate (EGCG), an active ingredient in green tea. The trial determined that patients with chronic lymphocytic leukemia (CLL) can tolerate the chemical fairly well […]